| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Fulvestrant |
氟維司群 |
129453-61-8 |
詳細(xì)
|
| Abiraterone acetate |
醋酸阿比特龍 |
154229-18-2 |
詳細(xì)
|
| Capecitabine |
卡培他濱 |
154361-50-9 |
詳細(xì)
|
| Finerenone |
非奈利酮 |
1050477-31-0 |
詳細(xì)
|
| Mirogabalin besylate |
苯磺酸美洛加巴林 |
1138245-21-2 |
詳細(xì)
|
| Upadacitinib |
烏帕替尼 |
1310726-60-3 |
詳細(xì)
|
| Sodium nitroprusside dihydrate |
硝普鈉;硝普鈉二水合物 |
13755-38-9 |
詳細(xì)
|
| Niraparib tosylate |
甲苯磺酸尼拉帕利;MK-4827 |
1038915-73-9 |
詳細(xì)
|
| Ilaprazole Sodium |
艾普拉唑鈉 |
172152-50-0 |
詳細(xì)
|
| OMadacycline (tosylate) |
甲苯磺酸奧馬環(huán)素 |
1075240-43-5 |
詳細(xì)
|
| Emedastine Fumarate |
富馬酸依美斯汀 |
87233-62-3 |
詳細(xì)
|
| 2-Bromo-N,N-DIethylethylamine Hydrobromide |
2-二乙氨基-1-溴乙烷氫溴酸鹽 |
1069-72-3 |
詳細(xì)
|
| Dotinurad |
多替諾雷;多替諾德 |
1285572-51-1 |
詳細(xì)
|
| benzo[d]thiazol-3(2H)-yl(3,5-dichloro-4-methoxyphenyl)methanone |
3-(3,5-二氯-4-甲氧基苯甲?；?-1,2-二氫-3H-1,3-苯并噻唑;多替諾雷中間體;多替諾雷雜質(zhì)C |
1285573-42-3 |
詳細(xì)
|
| (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS,E)-8-ethyl-5,19-dihydroxy-14,16-dimethoxy-3-((E)-1-((1R,5R)-5-methoxycyclohex-3-en-1-yl)prop-1-en-2-yl)-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
吡美莫司三烯類似物；
吡美莫司雜質(zhì)；
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-[(1R,3Z,5R)-3-烯-5-甲氧基環(huán)已基]-1-甲基乙烯基]-17-乙基-1,14-二羥基-23,25-二甲氧基-13,19,21,27-四甲基-11,28-二噁-4-氮雜三環(huán)[22.3.1.04,9]二十八碳-18-烯-2,3,10,16-四酮 |
148147-41-5 |
詳細(xì)
|
| (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS,E)-8-ethyl-5,19-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
子囊霉素；
吡美莫司雜質(zhì)；
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-[(1R,3R,4R)-4-羥基-3-甲氧基環(huán)已基]-1-甲基乙烯基]-17-乙基-1,14-二羥基-23,25-二甲氧基-13,19,21,27-四甲基-11,28-二噁-4-氮雜三環(huán)[22.3.1.04,9]二十八碳-18-烯-2,3,10,16-四酮 |
104987-12-4 |
詳細(xì)
|
| Elagolix |
噁拉戈利 |
834153-87-6 |
詳細(xì)
|
| 3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS,E)-3-((E)-1-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)prop-1-en-2-yl)-5,19-dihydroxy-14,16-dimethoxy-4,8,10,12,18-pentamethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
脫甲基吡美莫司；
吡美莫司雜質(zhì)；
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-[(1R,3R,4S)-4-氯-3-甲氧基環(huán)已基]-1-甲基乙烯基]-17-甲基-1,14-二羥基-23,25-二甲氧基-13,19,21,27-四甲基-11,28-二噁-4-氮雜三環(huán)[22.3.1.04,9]二十八碳-18-烯-2,3,10,16-四酮 |
1025113-89-6 |
詳細(xì)
|
| Carfilzomib |
卡非佐米 |
868540-17-4 |
詳細(xì)
|
| B-dimethylaminoethyl bromide hydrobromide |
二甲氨基溴乙烷氫溴酸鹽 |
2862-39-7 |
詳細(xì)
|
| (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS,E)-5,19-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,8,10,12,18-pentamethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
脫甲基子囊霉素；
吡美莫司雜質(zhì)；
(1R,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-[(1R,3R,4R)-4-羥基-3-甲氧基環(huán)已基]-1-甲基乙烯基]-17-甲基-1,14-二羥基-23,25-二甲氧基-13,19,21,27-四甲基-11,28-二噁-4-氮雜三環(huán)[22.3.1.04,9]二十八碳-18-烯-2,3,10,16-四酮 |
1285573-44-5 |
詳細(xì)
|
| Carboplatin |
卡鉑 |
41575-94-4 |
詳細(xì)
|
| (3S,4R,5E,8R,9E,12S,14S,15R,16S,18R,19R,26aS)-3-((E)-1-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)prop-1-en-2-yl)-8-ethyl-19-hydroxy-14,16-dimethoxy-4,10,12,18-tetramethyl-8,11,12,13,14,15,16,17,18,19,24,25,26,26a-tetradecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone |
吡美莫司雜質(zhì)；
(1R,9S,12S,13R,17R,18E,21S,23S,24R,25S,27R)-12-[(1E)-2-[(1R,3R,4S)-4-氯-3-甲氧基環(huán)已基]-1-甲基乙烯基]-17-乙基-1-羥基-23,25-二甲氧基-13,19,21,27-四甲基-11,28-二噁-4-氮雜三環(huán)[22.3.1.04,9]二十八碳-14,18-烯-2,3,10,16-四酮 |
161486-47-1 |
詳細(xì)
|
| Vonoprazan Fumarate |
富馬酸伏諾拉生 |
1260141-27-2 |
詳細(xì)
|
| Desmethyl Ascomycin |
去甲基子囊霉素 |
|
詳細(xì)
|